Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2015

Conditions
Pancreatic Cancer
Interventions
DRUG

Oxaliplatin

DRUG

5FU

RADIATION

Radiation

PROCEDURE

Surgery

DRUG

FOLFOX 6

this is an established regimen of Oxaliplatin+infusional 5FU/Leucovorin

Trial Locations (2)

10016

Bellevue Hospital, New York

NYU Cancer Institute, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

NYU Langone Health

OTHER

NCT00463840 - Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter